The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa
Abstract
Efflux pump systems are one of the most important mechanisms conferring multidrug resistance in Pseudomonas aeruginosa. MexAB-OprM efflux pump is one of the largest multi-drug resistant efflux pumps with high-level expression, which is controlled by regulatory genes mexR, nalC, and nalD. This study investigated the role of efflux pump MexAB-OprM in 75 strains of carbapenem-resistant P. aeruginosa and evaluated the influence of point mutation of the regulatory genes. The minimum inhibitory concentrations of imipenem and meropenem, with or without MC207110, an efflux pump inhibitor, were determined by agar dilution method to select the positive strains for an overexpressed active efflux pump. Carba NP test and EDTA-disk synergy test were used for the detection of carbapenemase and metallo-β-lactamases, respectively. The gene mexA, responsible for the fusion protein structure, and the reference gene rpoD of the MexAB-OprM pump were amplified by real-time PCR. The quantity of relative mRNA expression was determined simultaneously. By PCR method, the efflux regulatory genes mexR, nalC, and nalD and outer membrane protein OprD2 were amplified for the strains showing overexpression of MexAB-OprM and subsequently analyzed by BLAST. Among the 75 P. aeruginosa strains, the prevalence of efflux pump-positive phenotype was 17.3 % (13/75). Carba NP test and EDTA-disk synergy test were all negative in the 13 strains. PCR assay results showed that ten strains overexpressed the MexAB-OprM efflux pump and were all positive for the regulatory genes mexR, nalC, and nalD. Sequence analysis indicated that of the ten isolates, nine had a mutation (Gly → Glu) at 71st amino acid position in NalC, and eight also had a mutation (Ser → Arg) at 209th position in NalC. Only one strain had a mutation (Thr → Ile) at the 158th amino acid position in NalD, whereas eight isolates had mutations in MexR. In conclusion, overexpression of efflux pump MexAB-OprM plays an important role in carbapenem-resistant P. aeruginosa. The mutations of regulatory genes may be a main factor contributing to overexpression of MexAB-OprM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, overexpression of the efflux pumps Cdr1, Cdr2, or Mdr1 is a common way adopted by C. albicans to detoxify itself from xenobiotics [100]; P. aeruginosa does the same with MexAB-OprM and MexXY-OprM [101], and S. enterica serovar Typhimurium increases the levels of AcrB to excrete β-lactam antibiotics [102].”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [101]
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Pseudomonas aeruginosa – a phenomenon of bacterial resistance
Strateva, T., & Yordanov, D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009142-0 · Cited by 803
Yong, D., Lee, K., Yum, J. H., Shin, H. B., Rossolini, G. M., & Chong, Y. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3798-3801.2002 · Cited by 538
Quale, J., Bratu, S., Gupta, J., & Landman, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1633-1641.2006 · Cited by 409
Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E., & Bianco, N. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2021 · Cited by 324
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-06 · Cited by 293
Schweizer, H. P. (2003) · PubMed · Cited by 287
Castanheira, M., Deshpande, L. M., Costello, A., Davies, T. A., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku048 · Cited by 208
Cao, L., Srikumar, R., & Poole, K. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04210.x · Cited by 159
Sobel, M. L., Hocquet, D., Cao, L., Plésiat, P., & Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1782-1786.2005 · Cited by 138
Xavier, D. E., Picão, R. C., Girardello, R., et al. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-217 · Cited by 115
Pournaras, S., Maniati, M. A., Spanakis, N., Ikonomidis, A., Tassios, P. T., Tsakris, A., Legakis, N. J., & Maniatis, A. N. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki296 · Cited by 90
Wang, J., Zhou, J., Qu, T., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.014 · Cited by 89
The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa
Terzi, H. A., Külah, C., & Çiftçi, İ. H. (2014) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-014-1692-2 · Cited by 75
Protein Modulator of Multidrug Efflux Gene Expression inPseudomonas aeruginosa
Daigle, D. M., Cao, L., Fraud, S., Wilke, M. S., Pacey, A., Klinoski, R., Strynadka, N. C. J., Dean, C. R., & Poole, K. (2007) · Journal of Bacteriology · doi:10.1128/jb.00543-07 · Cited by 68
OprD mutations and inactivation in imipenem-resistant Pseudomonas aeruginosa isolates from China
Fang, Z.-L., Zhang, L., Huang, Y.-M., et al. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.10.027 · Cited by 61
OXA-198, an Acquired Carbapenem-Hydrolyzing Class D β-Lactamase from Pseudomonas aeruginosa
Garch, F. E., Bogaerts, P., Bebrone, C., Galleni, M., & Glupczynski, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00522-11 · Cited by 58
Rojo‐Bezares, B., Estepa, V., Cebollada, R., et al. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.01.001 · Cited by 55
Arabestani, M. R., Rajabpour, M., Mashouf, R. Y., et al. (2015) · PubMed · Cited by 48
Sonnet, P., Izard, D., & Mullié, C. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.08.005 · Cited by 47
Shen, J., Pan, Y.-P., & Fang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139995 · Cited by 37
Self-citationEfflux Pump Contribution to Multidrug Resistance in Clinical Isolates of Pseudomonas aeruginosa
Kiser, T. H., Obritsch, M. D., Jung, R., et al. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.7.632 · Cited by 37
Andrésen, C., Jalal, S., Aili, D., Wang, Y., Islam, S., Jarl, A., Liedberg, B., Wretlind, B., Mårtensson, L., & Sunnerhagen, M. (2010) · Protein Science · doi:10.1002/pro.343 · Cited by 36
Choudhury, D., Talukdar, A. D., Choudhury, M. D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133842 · Cited by 35
Meletis, G., Vavatsi, N. A., Exindari, M., Protonotariou, E., Sianou, E., Haitoglou, C., Sofianou, D., Pournaras, S., & Diza, E. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1952-3 · Cited by 34
Kolaylı, F., Karadenizli, A., Savlı, H., et al. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45692-0 · Cited by 32
Zheng, B. (2012) · The Chinese Journal of Clinical Pharmacology · Cited by 4
Study on the multi-drug efflux pump of carbapenem-resistant Pseudomonas aeruginosa
De-me, Z. (2011) · Zhongguo kangganran hualiao zazhi · Cited by 1
Cited by
Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
Caldara, M., & Marmiroli, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090915 · Cited by 54
Metadata
- Authors
- Pan, Y.-P., Xu, Y.-H., Wang, Z.-X., Fang, Y.-P., & Shen, J.-L.
- Affiliations
- Anhui Medical University (CN)
- Venue
- Archives of Microbiology
- Published
- 2016-04-08
- Volume
- 198
- Issue
- 6
- Pages
- 565-571
- ISSN
- 0003-9276 (ISSN-L)
- 0302-8933
- 1432-072X
- OpenAlex
- W2320908052
- Cited by
- 98
- References
- 30
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 13 · 2023: 15 · 2022: 9 · 2021: 15 · 2020: 8 · 2019: 10 · 2018: 5 · 2017: 2
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Fund Project (81171618)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- carbapenem resistance, Pseudomonas aeruginosa, multidrug resistance, efflux pump overexpression, mexR, imipenem, meropenem, MexA
- MeSH terms
- Meropenem, Anti-Bacterial Agents, Bacterial Outer Membrane Proteins, Bacterial Proteins, beta-Lactamases, Genes, Regulator, Humans, Microbial Sensitivity Tests, Mutation, Phenotype, Pseudomonas aeruginosa, Repressor Proteins, Thienamycins, Carbapenems, Drug Resistance, Multiple, Bacterial, Membrane Transport Proteins, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.